Upscaling key ecosystem functions across the conterminous United States by a water-centric ecosystem model

We developed a water-centric monthly scale simulation model (WaSSI-C) by integrating empirical water and carbon flux measurements from the FLUXNET network and an existing water supply and demand accounting model (WaSSI). The WaSSI-C model was evaluated with basin-scale evapotranspiration (ET), gross ecosystem productivity (GEP), and net ecosystem exchange (NEE) estimates by multiple independent methods across 2103 eight-digit Hydrologic Unit Code watersheds in the conterminous United States from 2001 to 2006. Our results indicate that WaSSI-C captured the spatial and temporal variability and the effects of large droughts on key ecosystem fluxes. Our modeled mean (±standard deviation in space) ET (556 ± 228 mm yr−1) compared well to Moderate Resolution Imaging Spectroradiometer (MODIS) based (527 ± 251 mm yr−1) and watershed water balance based ET (571 ± 242 mm yr−1). Our mean annual GEP estimates (1362 ± 688 g C m−2 yr−1) compared well (R2 = 0.83) to estimates (1194 ± 649 g C m−2 yr−1) by eddy flux-based EC-MOD model, but both methods led significantly higher (25–30%) values than the standard MODIS product (904 ± 467 g C m−2 yr−1). Among the 18 water resource regions, the southeast ranked the highest in terms of its water yield and carbon sequestration capacity. When all ecosystems were considered, the mean NEE (−353 ± 298 g C m−2 yr−1) predicted by this study was 60% higher than EC-MOD\u27s estimate (−220 ± 225 g C m−2 yr−1) in absolute magnitude, suggesting overall high uncertainty in quantifying NEE at a large scale. Our water-centric model offers a new tool for examining the trade-offs between regional water and carbon resources under a changing environment

Hydrologic Processes of Forested Headwater Watersheds Across a Physiographic Gradient in the Southeastern United States

2008 S.C. Water Resources Conference - Addressing Water Challenges Facing the State and Regio

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.

Importance: Iron deficiency is present in approximately 50% of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) and is an independent predictor of reduced functional capacity and mortality. However, the efficacy of inexpensive readily available oral iron supplementation in heart failure is unknown. Objective: To test whether therapy with oral iron improves peak exercise capacity in patients with HFrEF and iron deficiency. Design, Setting, and Participants: Phase 2, double-blind, placebo-controlled randomized clinical trial of patients with HFrEF ( Interventions: Oral iron polysaccharide (n = 111) or placebo (n = 114), 150 mg twice daily for 16 weeks. Main Outcomes and Measures: The primary end point was a change in peak oxygen uptake (V̇o2) from baseline to 16 weeks. Secondary end points were change in 6-minute walk distance, plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, and health status as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ, range 0-100, higher scores reflect better quality of life). Results: Among 225 randomized participants (median age, 63 years; 36% women) 203 completed the study. The median baseline peak V̇o2 was 1196 mL/min (interquartile range [IQR], 887-1448 mL/min) in the oral iron group and 1167 mL/min (IQR, 887-1449 mL/min) in the placebo group. The primary end point, change in peak V̇o2 at 16 weeks, did not significantly differ between the oral iron and placebo groups (+23 mL/min vs -2 mL/min; difference, 21 mL/min [95% CI, -34 to +76 mL/min]; P = .46). Similarly, at 16 weeks, there were no significant differences between treatment groups in changes in 6-minute walk distance (-13 m; 95% CI, -32 to 6 m), NT-proBNP levels (159; 95% CI, -280 to 599 pg/mL), or KCCQ score (1; 95% CI, -2.4 to 4.4), all P \u3e .05. Conclusions and Relevance: Among participants with HFrEF with iron deficiency, high-dose oral iron did not improve exercise capacity over 16 weeks. These results do not support use of oral iron supplementation in patients with HFrEF. Trial Registration: clinicaltrials.gov Identifier: NCT02188784

Monthly land cover-specific evapotranspiration models derived from global eddy flux measurements and remote sensing data

Evapotranspiration (ET) is arguably the most uncertain ecohydrologic variable for quantifying watershed water budgets. Although numerous ET and hydrological models exist, accurately predicting the effects of global change on water use and availability remains challenging because of model deficiency and/or a lack of input parameters. The objective of this study was to create a new set of monthly ET models that can better quantify landscape-level ET with readily available meteorological and biophysical information. We integrated eddy covariance flux measurements from over 200 sites, multiple year remote sensing products from the Moderate Resolution Imaging Spectroradiometer (MODIS), and statistical modelling. Through examining the key biophysical controls on ET by land cover type (i.e. shrubland, cropland, deciduous forest, evergreen forest, mixed forest, grassland, and savannas), we created unique ET regression models for each land cover type using different combinations of biophysical independent factors. Leaf area index and net radiation explained most of the variability of observed ET for shrubland, cropland, grassland, savannas, and evergreen forest ecosystems. In contrast, potential ET (PET) as estimated by the temperaturebased Hamon method was most useful for estimating monthly ET for deciduous and mixed forests. The more data-demanding PET method, FAO reference ET model, had similar power as the simpler Hamon PET method for estimating actual ET. We developed three sets of monthly ET models by land cover type for different practical applications with different data availability. Our models may be used to improve water balance estimates for large basins or regions with mixed land cover types

Remnants of an ancient forest provide ecological context for Early Miocene fossil apes

The lineage of apes and humans (Hominoidea) evolved and radiated across Afro-Arabia in the early Neogene during a time of global climatic changes and ongoing tectonic processes that formed the East African Rift. These changes probably created highly variable environments and introduced selective pressures influencing the diversification of early apes. However, interpreting the connection between environmental dynamics and adaptive evolution is hampered by difficulties in locating taxa within specific ecological contexts: time-averaged or reworked deposits may not faithfully represent individual palaeohabitats. Here we present multiproxy evidence from Early Miocene deposits on Rusinga Island, Kenya, which directly ties the early ape Proconsul to a widespread, dense, multistoried, closed-canopy tropical seasonal forest set in a warm and relatively wet, local climate. These results underscore the importance of forested environments in the evolution of early apes

An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.

This article explores aspects of family environment and parent-child conflict that may predict or moderate response to acute treatments among depressed adolescents (N = 439) randomly assigned to fluoxetine, cognitive behavioral therapy, their combination, or placebo. Outcomes were Week 12 scores on measures of depression and global impairment. Of 20 candidate variables, one predictor emerged: Across treatments, adolescents with mothers who reported less parent-child conflict were more likely to benefit than their counterparts. When family functioning moderated outcome, adolescents who endorsed more negative environments were more likely to benefit from fluoxetine. Similarly, when moderating effects were seen on cognitive behavioral therapy conditions, they were in the direction of being less effective among teens reporting poorer family environments

Model comparisons for estimating carbon emissions from North American wildland fire

Research activities focused on estimating the direct emissions of carbon from wildland fires across North America are reviewed as part of the North American Carbon Program disturbance synthesis. A comparison of methods to estimate the loss of carbon from the terrestrial biosphere to the atmosphere from wildland fires is presented. Published studies on emissions from recent and historic time periods and five specific cases are summarized, and new emissions estimates are made using contemporary methods for a set of specific fire events. Results from as many as six terrestrial models are compared. We find that methods generally produce similar results within each case, but estimates vary based on site location, vegetation (fuel) type, and fire weather. Area normalized emissions range from 0.23 kg C m−2 for shrubland sites in southern California/NW Mexico to as high as 6.0 kg C m−2 in northern conifer forests. Total emissions range from 0.23 to 1.6 Tg C for a set of 2003 fires in chaparral-dominated landscapes of California to 3.9 to 6.2 Tg C in the dense conifer forests of western Oregon. While the results from models do not always agree, variations can be attributed to differences in model assumptions and methods, including the treatment of canopy consumption and methods to account for changes in fuel moisture, one of the main drivers of variability in fire emissions. From our review and synthesis, we identify key uncertainties and areas of improvement for understanding the magnitude and spatial-temporal patterns of pyrogenic carbon emissions across North America

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.

BACKGROUND: Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. We compared the effect of isosorbide mononitrate or placebo on daily activity in such patients. METHODS: In this multicenter, double-blind, crossover study, 110 patients with heart failure and a preserved ejection fraction were randomly assigned to a 6-week dose-escalation regimen of isosorbide mononitrate (from 30 mg to 60 mg to 120 mg once daily) or placebo, with subsequent crossover to the other group for 6 weeks. The primary end point was the daily activity level, quantified as the average daily accelerometer units during the 120-mg phase, as assessed by patient-worn accelerometers. Secondary end points included hours of activity per day during the 120-mg phase, daily accelerometer units during all three dose regimens, quality-of-life scores, 6-minute walk distance, and levels of N-terminal pro-brain natriuretic peptide (NT-proBNP). RESULTS: In the group receiving the 120-mg dose of isosorbide mononitrate, as compared with the placebo group, there was a nonsignificant trend toward lower daily activity (-381 accelerometer units; 95% confidence interval [CI], -780 to 17; P=0.06) and a significant decrease in hours of activity per day (-0.30 hours; 95% CI, -0.55 to -0.05; P=0.02). During all dose regimens, activity in the isosorbide mononitrate group was lower than that in the placebo group (-439 accelerometer units; 95% CI, -792 to -86; P=0.02). Activity levels decreased progressively and significantly with increased doses of isosorbide mononitrate (but not placebo). There were no significant between-group differences in the 6-minute walk distance, quality-of-life scores, or NT-proBNP levels. CONCLUSIONS: Patients with heart failure and a preserved ejection fraction who received isosorbide mononitrate were less active and did not have better quality of life or submaximal exercise capacity than did patients who received placebo. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov number, NCT02053493.)